论文信息 - Neoadjuvant Selective COX-2 Inhibition Down-Regulates Important Oncogenic Pathways in Patients With Esophageal Adenocarcinoma - 字舞流文

Neoadjuvant Selective COX-2 Inhibition Down-Regulates Important Oncogenic Pathways in Patients With Esophageal Adenocarcinoma

J. Tuynman | C. Buskens | D. Richel | F. T. ten Kate | J. V. van Lanschot | G. Offerhaus | K. Kemper | F. ten Kate | J. V. van Lanschot | G. Offerhaus | D. Richel